ID: ALA4798237

Max Phase: Preclinical

Molecular Formula: C13H13NO4

Molecular Weight: 247.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Oc1cc(O)cc(NCc2ccc(O)c(O)c2)c1

Standard InChI:  InChI=1S/C13H13NO4/c15-10-4-9(5-11(16)6-10)14-7-8-1-2-12(17)13(18)3-8/h1-6,14-18H,7H2

Standard InChI Key:  XJMBACOKSZZKOU-UHFFFAOYSA-N

Associated Targets(non-human)

Arginase-1 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.25Molecular Weight (Monoisotopic): 247.0845AlogP: 2.12#Rotatable Bonds: 3
Polar Surface Area: 92.95Molecular Species: NEUTRALHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.07CX Basic pKa: 3.09CX LogP: 1.96CX LogD: 1.95
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.54Np Likeness Score: 0.28

References

1. Muller, J., Cardey, B., Zedet, A., Desingle, C., Grzybowski, M., Pomper, P., Foley, S., Harakat, D., Ramseyer, C., Girard, C., Pudlo, M..  (2020)  Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors,  11  (5): [PMID:33479657] [10.1039/d0md00011f]

Source